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Abstract  
Aryl oxazolines have been employed as directing groups for several different coupling reactions. In the 
exploration of using phenyl oxazoline as a directing group for electrophilic fluorination, it was discovered 
that acidic sulfonimide nucleophiles including dibenzenesulfonimide, o–benzenesulfonimide, 
dimethanesulfonimide, and N–(methylsulfonyl)–benzenesulfonamide are discovered to open a variety of 
alkyl, aryl and heteroaryl–2–oxazoline rings to provide the sulfonimidation products in refluxing 1,4–
dioxane. The electron rich 2–oxazoline substrates worked well for the nucleophilic ring opening reactions 
while no reaction took place for the electron poor 2–oxazoline substrates. 4,4–dimethyl–2–phenyl–2–
oxazoline was thus rationally designed inhibit sulfonimidation and to act as a removable ortho directing 
group for the palladium catalyzed C–H electrophilic fluorination of arenes. Using NFSI as the 
fluorinating agent, and a Pd(II), Ag(I) catalytic system, electrophilic C(sp2–H) ortho–fluorination took 
place on a variety of aryl substrates to afford the corresponding mono and di–fluorinated products. The 
oxazoline directing group was then hydrolyzed unmasking the carboxcylic acid moiety, demonstrating the 
synthetic utility of this reaction.  
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Chapter 1 The sulfomindation of aryl oxazolines via acidic nucleophilic addition of sulfonimides. 
1.1 Introduction 
Oxazolines are useful building blocks and ring opening reaction of oxazolines are well known.1,2 
For example, 2–substituted 1,3–oxazolines, have been used as starting monomers in the cationic 
polymerization reactions intended for making poly(ethylene imines) of various compositions and 
molecular weights.3,4 Another approach is through nucleophilic ring opening of oxazolines such as 2–
phenyl–2–oxazoline to give products. A variety of nucleophiles have been applied in this type of 
transformation. Thiophenols5 and thiols6 have been used as S–nucleophiles and phenols7 as O–
nucleophiles, C–nucleophiles in the form of stabilized carbanions have been also used to open oxazoline 
rings with the aid of methyl triflate.8 Halides as nucleophiles generally react with oxazolines in the form 
of TMS–X.9 Other nucleophiles that have been used to open oxazoline rings also include selenium10 and 
tellurium11 containing nucleophiles. More interestingly, N–nucleophiles have found synthetic utility in 
opening oxazoline rings. For instance, imidazole was used to open the oxazoline ring,12 as was azide in 
form of TMSN3.13 In the presence of a Brønsted–Lowry or Lewis acid, amines such as diphenylamine 
bring about a nucleophilic ring opening of 2–ethyl–2–oxazoline at high temperature offering a synthesis 
of unsymmetrically substituted ethylenediamines.14  
In the development of ortho directed palladium–catalyzed electrophilic fluorination using 
dimethyl oxazoline as DG it was discovered that N–fluorobenzenesulfonimide (NFSI) is able to act as an 
acidic nucleophile and ring open unsubsitituted oxazolines. NFSI a typical fluorinating agent, up to our 
knowledge, has not been previously reported in the literature as a nucleophile. The two electron with 
drawing sulfonyl groups render the nitrogen atom electron deficient and typically non–nucleophilic.  
N–fluorobenzenesulfonimide (NFSI) is an electrophilic fluorinating agent that permits the 
incorporation of fluorine into neutral molecules as well as nucleophilic substrates ranging in strength 
from very reactive organometallic species to highly stabilized malonate anions. The use of NFSI does not 
involve any special equipment or techniques in handling, and it does not attack glass like most fluoride–
containing reagents.15  
In the process of pursuing our on going interest in fluorination via C–H activation, it was 
discovered that N–fluorobenzenesulfonimide (NFSI) was able to open the oxazoline ring on 1 to afford 
sulfonimide 2 in 15% yield (Scheme1). The importance of sulfonimides as important bioisosteres of 
carboxylic acids in medicinal chemistry,16-19 led to the exploration of the scope and limitations of this 
unique ring–opening sulfonimidation reaction. 
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Scheme 1: In the process of investigating electrophilic fluorination, no fluorination occurred. 
Instead ring opening of oxazoline was the predominate product 
 
1.2 Results and discussion 
The acidic dibenzenesulfonimide [HN(SO2Ph)2] was able to serve as a nucleophile to convert 2–
phenyl–2–oxazoline into sulfonimide in 93% yield. Different oxazoline substrates were investigated. The 
oxazoline derivatives were prepared via a 2–step sequence consisting of amide formation from carboxylic 
acid chloride and 2–chloroethylamine•HCl,20 followed by ring closure of the resulting amido–chloride 
with the aid of NaOH (Scheme 2).21 
 
Scheme 2: Synthesis of aryl oxazolines from carboxylic acids via a 2–step sequence. 
 
Initially the solvent effect for transformation of 1 to 5 was screened. When the reaction was 
heated in polar solvents including DMF and DMSO no reaction was observed even at 150 oC for a 
prolonged period of time. The reaction took place in solvents such as EtOH, n–BuOH and isopentanol. 
The reaction did stall at approximately 70% conversion. In ethereal solvents the reaction went to 
completion. Solvents such as methyl t–butyl ether (MTBE), THF, and 1,4–dioxane all gave complete 
conversion to the desired product. Because 1,4–dioxane had the highest boiling point, it was selected as 
the solvent of choice. 
Observations of the solvent on the effect of the addition reaction could be attributed to the 
solvation effect of the nucleophile. Polar solvents such as DMF and DMSO can solvate the nucleophilic 
sulfonimide and dispersing the negative charge on the nitrogen throughout the molecule and thus lower 
the energy of the nucleophile. However ethereal solvents such as 1,4–dioxane can have an opposite effect. 
The lower dielectric constant of the ethereal solvents can presumably cause the negative charge to reside 
largely on the nitrogen of the imide. This lack of electron distribution causes the nucleophile to be 
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“harder” and more reactive than in polar solvents.  
Stark differences were observed for electron rich and electron poor 2–oxazoline substituted aryls 
(Table 1). The reaction between 2–phenyl–2–oxazoline 1 and dibenzenesulfonimide in refluxing 1,4–
dioxane gave 93% yield and the same reaction for 2 (p–methoxyphenyl)–2–oxazoline 5 gave 72%. 2–
ethyl–2–oxazoline 3 behaved similarly to 2–phenyl–2–oxazoline, 1, and all the reactions were complete 
within 2 hours. Substrates containing The electron rich hetero–aryls thiophene 7, 9, and furan 11, and 13 
reacted smoothly with HN(SO2Ph)2. However, this methodology did not work for electron poor 
substrates. For example, no reaction was observed when 2–(4–nitrophenyl)–2–oxazoline 15 and 
HN(SO2Ph)2 were heated together. The same phenomenon was observed for another electron–poor 
substrate 2–(pyridin–4–yl)–2–oxazoline 17, derived from isonicotinic acid. The experimental results of 
these substituted aryl oxazolines were used in establishing a mechanism for this addition reaction. 
 
Table 1: Sulfonimidation of substituted oxazolines via nucleophilic ring opening with 
dibenzenesulfonimide 
Substrates Products Reaction Time (min) Yield
NO
NO
NO
NO
NO
H
NO N(SO2Ph)2
45 93
H
NO N(SO2Ph)2 30 75
H
NO N(SO2Ph)2
O O
90 72
S
S
H
NO N(SO2Ph)2
S
H
NO N(SO2Ph)2
S
120 93
120 94
1 2
3 4
5 6
7 8
9 10
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Table1 cont’d: Sulfonimidation of substituted oxazolines via nucleophilic ring opening with 
dibenzenesulfonimide 
 
Before the mechanism could be further elucidated additional imide nucleophiles for this ring 
opening reaction were explored. The N–(phenylsulfonyl)acetamide 20 was prepared by treating a 
suspension of benzenesulfonamide 19 in CH2Cl2 with acetic anhydride in the presence of a catalytic 
amount of TiCl4.22 2,2,2–Trifluoro–N–(phenylsulfonyl)acetamide 21 was synthesized in the same manner 
using trifluoroacetic anhydride.22 N–(methylsulfonyl)benzenesulfonamide 23 was assembled in 35% yield 
by the reaction between benzenesulfonamide and methanesulfonyl chloride in the presence of Et3N and a 
catalytic amount of DMAP (Scheme 3). Unfortunately, the resulting ring opened products, from these 
nucleophiles, were not stable on silica gel and less than 27% of products were able to be isolated.  
NO
NO
O
O
H
NO N(SO2Ph)2
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H
NO N(SO2Ph)2
O
120 73
120 73
NO
H
NO N(SO2Ph)2
N
NO
N
H
NO N(SO2Ph)2
NO2 NO2
360 0
360 0
11 12
13 14
15 16
17 18
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Scheme 3: Preparation of additional sulfonimide nucleophiles  
The reaction conditions for the preparation of 23 were surprisingly the only method to prepare 
this compound. However the cyclic arylsulfonimide dimethanesulfonimide and mixed sulfonimide all 
worked well in the ring opening reaction. Further, both nucleophiles dimethanesulfonimide and mixed 
sulfonimide worked on alkyl, aryl and hetero–aryloxazolines to produce the ring opening products with 
yields ranging from 56% to 84% (Table 2). However other imides such as phthalimide and 
benzenesulfonamide did not yield any ring opened product.  
S OO
NH2
O(COR)2, cat. TiCl4
CH2Cl2, rt, 2 h
CH3SO2Cl, Et3N
DMAP, CH2Cl2
overnight, 35%
S
O
O
NH
S
O
O HN O
R
S
OO
20 R = CH3, 92%21 R = CF3, 88%
19
23
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Table 2: Sulfonimidation of substituted oxazolines via nucleophilic ring opening reaction with 
additional sulfonimide nucleophiles  
 
Substrates Products Reaction Time (min) Yield
NO
NO
NO
H
NO
H
NO N
S
NO
O
H
NO
S
H
NO N
O
N
O2S
O2
S
O2S
O2
S
N
O2S
O2
S
O2S
O2
S
NO
NO
NO
S
O
H
NO N(SO2CH3)2
H
NO N(SO2CH3)2
H
NO N(SO2CH3)2
S
O
1 25
26
27
28
29
30
31
3
7
11
1
5
9
45 95
30 89
120 95
120 80
56
62
70
120
100
95
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Table 2 cont’d: Sulfonimidation of substituted oxazolines via nucleophilic ring opening reaction 
with additional sulfonimide nucleophiles. 
 
The experimental results indicate that the reaction is driven by the acidity of the substituted 
oxazoline and the acidity of the reactive sulfonimide. 2–Phenyl–2–oxazoline has a pKa of 4.4.23 Electron 
donating substituents donate electrons to the oxazoline ring, increasing the pKa and promoting 
NO
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S
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S
O2S Ph
CH3
32
33
34
35
36
11
1
3
7
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Substrates Products Reaction Time (min) Yield
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1
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O37
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360
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0
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protonation.23 On the other hand, electron accepting 2–substituents withdraw electrons from the oxazoline 
ring so that the nitrogen is no longer as basic as 2–phenyl–2–oxazoline and the reaction does not proceed. 
The two powerful electron withdrawing phenylsulfonyl groups, in NHSI render the NH proton on the 
molecule exceptionally acidic with a pKa value of 1.45, approximately as strong as phosphoric acid.24 As 
a result, dibenzenesulfonimide is acidic enough to protonate the nitrogen atom on the oxazoline 1' 
(Scheme 4). Indeed, moved to the baseline on TLC when HN(SO2Ph)2 were stirred in 1,4 dioxane at room 
temperature. The intermediacy of protonated oxazoline accounts for the disparity between electron rich 
and electron poor oxazolines. 
 
Scheme 4: Proposed reaction mechanism  
 
To further confirm the intermediacy of protonated oxazoline, the addition of 1 equivalent of 
sodium hydride to the reaction did not yield any ring–opened product. Indicating that the protonation of 
the oxazoline nitrogen is essential for the reaction. This also indicates a specific acid catalysis. The 
(PhSO2)2N¯ anion25 can then serve as a nucleophile to open the oxazoline ring in an SN2 fashion to 
furnish the imidation product 2. It is suspected that a nucleophile with similar acidity to HN(SO2Ph)2 
would be more amenable to such transformations. Nucleophiles such as phthalimide and 
benzenesulfonamide have pKa’s of 8.3 and 10.1 respectively, and are too basic to furnish intermediate. 
However the cyclicarylsulfonimide dimethanesulfonimide and mixed sulfonimide presumably have 
acidities near the pKa of NHSI. The relatively moderate yields for reactions involving alkylsulfonimides 
can possibly be attributed to alkylsulfonimides being less acidic than aryl–sulfonimides. 
Sterically hindered oxazolines did not react in attempted ring openings using this methodology. 
This is most likely due to the fact that steric hindrance of the a neopentyl carbon cannot accommodate the 
bulky nucleophile, (PhSO2)2N¯ (Scheme 5). 
N:O
N(SO2Ph)2H
NO H
N(SO2Ph)2
H
NO N(SO2Ph)2
1 1' 2
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Scheme 5: Unreactive sterically hindered aryl oxazolines. 
 
Many efforts were made to react the sulfonimide products with other nucleophiles such as azide, 
but these invariably produced the ring closed oxazoline, the very starting materials to make those linear 
amide sulfonimides. This is not completely surprising because once the NH bond on the amide encounters 
even weak basic conditions, the intramolecular ring–closure prevails because it is very much more 
kinetically favored than the intermolecular SN2 substitution, especially considering that sulfonimides are 
such good leaving groups. Therefore, the synthetic utility of the linear ring opening products are limited 
to their corresponding linear forms. 
1.3 Conclusion 
It was discovered that acidic sulfonimides can serve as nucleophiles to open 2–substituted 
oxazolines. This methodology of sulfonimidation works more efficiently for oxazoline substrates with an 
electron rich 2–substituent, while no reaction took place for oxazolines with electron poor 2 substituents. 
The resulting linear amide–sulfonimides may serve as bioisosteres of carboxylic acids in drug discovery. 
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Chapter 2: The electrophilic fluorination of aryl oxazolines 
2.1 Introduction 
 The introduction of fluorine has been widely used in medicinal chemistry, to boost potency, 
increase membrane permeability, modulate pKa, and block metabolic sites on potential drug molecules.26 
In addition, 18F–Labeled compounds are indispensable as radionuclides in radiotracers for positron 
emission tomography (PET). These unique properties make the introduction of fluorine to bioactive 
molecules intriguing. The construction of C–F bonds is very challenging,27,28 particularly in a selective 
late stage synthesis. However, recently there have been advances in ortho directed palladium catalyzed 
electrophilic fluorination of arenes via C–H activation.28 In 2006 Sanford used 8–methylquinolines and 
phenyl–pyridines to accomplish this transformation in acceptable yields and under microwave 
conditions.29 The Xu group has also shown that a wide variety of N–heterocyclic DGs such as 
quinoxaline, pyrazole, and benzo[d]oxazole can promote selective mono–ortho–fluorination using 
trifluoroacetic acid as an additive.30 A more expansive investigation into the electrophilic fluorination of 
aryls using benzo[d]oxazole and pyrazole as DGs has also been established.31,32 Experimental studies of 
the electrophilic fluorination of arylpyrazoles has shown evidence of an alternative mechanism to the 
standard Pd(II)/Pd(IV) process, suggesting a possible oxidative addition of N–fluorobenzenesulfonimide 
(NFSI) to Pd(II).30,32 Despite these recent advances in ortho directed palladium catalyzed electrophilic 
fluorination via C–H activation, many of the initial DGs were heteroaryls thus not easily removable thus 
limiting their synthetic utility. However a set of removable non–heteroaryl DGs have since been 
developed. The Xu group was able to demonstrate that O–methyloxime as a DG for ortho–fluorination of 
arenes at moderate temperatures.33 They also demonstrated the selective ortho–mono–fluorination of 2–
phenoxylpyridines via a six–membered cyclopalladation step.34 Yu has reported the fluorination of arenes 
using the –C(O)NHC6F4CF3 amide–DG, and was able to achieve selective mono–fluorination by 
increasing the acidity of the benzamide DG.35 Other benzamides such as oxalyl amide36 and triflamides37 
have also been shown to be suitable DGs for selective mono ortho–fluorination. These DGs are labile and 
their removal makes the aryls amenable for further synthetic transformations but most of the benzamides 
suffer from their large size and poor atom economy. Thus the development of a directing group that is 
both an N–heterocycle and removable with good atom is needed.  
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Figure 1: Examples of N–heterocylic and benzamide directing groups used for ortho directed 
fluorination 
 
Oxazolines are versatile ligands and directing groups in organic synthesis and useful building 
blocks. Oxazolines have been extensively used as chiral ligands for asymmetric synthesis.1,2 Aryl–2–
oxazolines have served as an important class of directing groups for metalation via complex–induced 
proximity effect (CIPE), also known as directed ortho–metalation (DoM), pioneered by Meyers, Beak, 
and Snieckus, et al.38,39 Aryloxazolines have been shown to be suitable DGs for C–C bond formation via 
C–H activation. Aryl–oxazolines have been fluorinated via ortho–metalation using magnesate bases and 
by lithiation.40 Oxazolines have also been shown to be amenable to further synthetic transfromations by 
hydrolysis to the carboxylic acid, with good atom economy.41 The development of a palladium catalyzed 
oxazoline ortho directed electrophilic fluorination takes advantage of the heterocyclic moiety to direct 
fluorination for late stage synthesis and can be hydrolyzed with good atom economy (Scheme 1).  
 
Scheme 1: Oxazoline directed C–H bond fluorination and hydrolysis 
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2.2 Results and Discussion 
 The investigation into fluorination began using 4,4–Dimethyl–2–phenyl–2–oxazoline because we 
have previously shown that ring opening occurred on 2–phenyl–oxazoline, 1, when N–
fluorobenzenesulfonimide (NFSI) was used as the electrophilic fluorine source and produces the 
corresponding sulfonimides 2, as the predominate product (Scheme 2).42 The dimethyl substituents add 
steric bulk to the oxazline and this was expected to hinder the ring opening reaction. 
 
Scheme 2: Sulfonamidation via nucleophilic ring opening of 2–oxazolines with acidic 
sulfonimides 
 
 The 4,4–dimethyl oxazoline derivatives were prepared using standard procedures. The 
corresponding benzoic acid was converted to the acyl chloride using oxalyl chloride and catalytic DMF, 
followed by formation of the amide using 2–amino–2–methyl–1–propanol. The corresponding alcohol 
was then mesylated and then cyclized using NaOH in ethanol in high yield (Scheme 3). 
 
 
Scheme 3: Procedures for the formation of substituted aryl oxazolines 
 
With the oxazoline in hand the model substrate 3 with several fluorinating agents (A, B, C, D, E, 
and F) that have been shown to be successful fluorinating agents (Table 1). DMF was initially used as the 
solvent of choice for the fluorination reactions because this polar solvent was shown to retard the ring 
opening of phenyl oxazolines.42 Pd(OAc)2 catalyst was used and TFA as an additive. NFSI (A) and 
Selectfluor (B) afforded the fluorinated product 4 in 28% and 13%, respectively (entry 1–2). The four 1–
fluoropyridinium–based fluorinating agents including [PyF]BF4 (C), [Cl2PyF]OTf (D), complex E, and 
[Me2PyF]BF4 (F) all failed to produce more than a trace amount of the desired product (entries 3–6). 
NO
SN
O
O
S
O
O
1,4-dioxane 100 oC
45 min
H
H
H
NO N(SO2Ph)2
H
2
93%1
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NFSI was selected as the fluorinating agent of choice and it was determined that five equivalents of TFA 
was needed to promote the fluorination reaction (Appendix B). A selection of Pd(II) and Pd(0) catalysts 
were screened (entry 8–12). Pd(0) catalysts gave low conversion to the fluorinated product (entry 8 and 
11).  Surprisingly Pd(TFA)2 did not give a significant boost in conversion (entry 7). This is in contrast to 
previously know reports, as using TFA along with Pd(TFA)2 increases amount of fluorination.30 Pd(NO3)2 
gave the best conversion to (entry 12). As a result of this catalyst giving superior conversion, a series of 
nitrates were screened as promoters but the use of KNO3 and Ca(NO3)2 completely halted the reaction 
(entry 13–14). Ag(NO3) gave the best conversion of all the screened nitrates (entry 15). Other silver salts 
were screened however none of these silver sources showed any effectiveness at promoting the reaction 
(entry 16–17). No trace of fluorinated product was detected when no additive was used. However it does 
appear that that the silver nitrate salt is unique in its ability to promote fluorination. Solvents that have 
promoted other fluorination reactions were then screened. Trifluorotoluene, 1,2–dichloroethane, ethyl 
acetate, and dioxane, gave no reaction. Nitromethane was able to give conversion to desired product 4 but 
acetonitrile gave the full conversion to the fluorinated product. It was also concluded that using 
acetonitrile as the solvent only 50–mol% of AgNO3 was needed to give full conversion to the desired 
product.  
 
Entry Pd cat. F+ source Promoter Solvent Yield (3:4)a 
1b Pd(OAc)2 A TFA DMF 72:28 
2b Pd(OAc)2 B TFA DMF 87:13 
3b Pd(OAc)2 C TFA DMF NR 
4b Pd(OAc)2 D TFA DMF NR 
5b Pd(OAc)2 E TFA DMF NR 
6b Pd(OAc)2 F TFA DMF NR 
7b Pd(TFA)2 A TFA DMF 71:29 
NO
H
NO
F
Pd cat, promoter
Fluorinating agent
solvent, temp
3 4
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8b Pd(dba)2 A TFA DMF 90:10 
9b PdCl2 A TFA DMF NR 
10b Pd(OTf)2 A TFA DMF 82:18 
11b Pd(PPh3)4 A TFA DMF 66:34 
12b Pd(NO3)2 A TFA DMF 60:40 
13c Pd(NO3)2 A KNO3 DMF 92:8 
14c Pd(NO3)2 A Ca(NO3)2 DMF 89:11 
15c Pd(NO3)2 A AgNO3 DMF 51:49 
16c Pd(NO3)2 A AgTFA DMF 100:0 
17c Pd(NO3)2 A AgOAc DMF 93:7 
18d Pd(NO3)2 A AgNO3 Dioxane NR 
19d Pd(NO3)2 A AgNO3 DCE 
NR 
20d Pd(NO3)2 A AgNO3 PhCF3 NR 
21d Pd(NO3)2 A AgNO3 CH3NO2 73:27 
22d Pd(NO3)2 A AgNO3 EtOAc NR 
23e Pd(NO3)2 A AgNO3 CH3CN 0:100 
Pd (20 mol %) aryloxazoline (0.1 mmol), NFSI (0.15 mmol), solvent (1 mL). aGCMS 
conversions using dodecane as an internal standard. bTFA (0.5 mmol) 150 oC. cAdditive (0.5mmol)  
150 oC. dAgNO3 (0.5mmol) 100 oC. eAgNO3 (50 mol%) 80 oC. 
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Table 1: Optimization of palladium–catalyzed fluorination of aryl 4,4–dimethyloxazoline 3 
 
Using the optimized reaction conditions (Table 2) the scope of the reaction was then explored. 
Electron rich oxazolines showed moderate to good yields of fluorinated products. The fluorination of 2–
o–tolyl substrate 4a and 2–o–methoxyl substrate 4b, gave moderate yields of fluorinated product. When 
the electron rich 4–p–methoxyl 4i was fluorinated the 2,6–difluorination product 5i was the major product 
with trace amounts of the monofluorinated observed by GCMS. Surprisingly 4–p–methyl 4h was only 
able to be fluorinated once despite increasing the amount of fluorinating agent used to 5 equivalents and 
increasing reaction time.  
Electron deficient oxazolines were not able to be fluorinated as readily as electron rich 
oxazolines. The unsubsititued oxazoline 4f gave the monofluorinated product in predominate yield 4c, 
46%, and gave minor conversion to the difluoro product, 5%. Similar results were observed when the 
reaction was carried out in nitromethane. This experimental result is in contrast of other fluorination 
reactions which show nitromethane further promote fluorination and even promote difluorination 
reactions. The fluorination of 2–o–fluoro derivative 5c gave only 19% isolated yield of the desired 
difluoro product 5c. This result was unexpected given the amount of difluorination occurring on 4f. The 
extremely deactivated 2–o–nitro oxazoline 4k, was completely unable to be fluorinated and 4–p–chloro 
substituted aryloxazoline 4l, showed only 13% GCMS conversion to the mono fluorinated product 5l, and 
no difluoro product was observed.  The stark lack of reactivity observed for the fluorination of electron 
deficient aryloxazolines than electron rich oxazolines is precedent for fluorination reactions.30 
The differences in the reactivity of electron rich and electron deficient oxazolines could be 
presumably attributed to the basicity of the nitrogen on the oxazoline. The 4,4–dimethyl–2–phenyl–2–
oxazoline 4h, has a pKa of 4.4 and the substituent effect on the aryl can either increase or decrease the 
basicity of the nitrogen.23 Electron donating substituents on aryls increase the basicity of the oxazolines 
	17 
and thus increase its ability to facilitate the fluorination reaction. Where as electron poor aryls decrease 
the basicity of the nitrogen and shifts the equilibrium to the left.  
Other effects of substituted aryl oxazolines were also investigated. Ortho chloro and bromo 
halides 4d and 4e were tolerated in the reaction and gave good to moderate yields respectively. The 
fluorination of 3–m–tolyl 4g was low yielding and gave predominantly the less sterically hindered 
product 5g. The naphthalene derivative 4j gave impressive yield of the monofluorinated product 5j at the 
2–position, 88% and 7% of the 2,8–difluorinated product 5k. However increasing the amount of NFSI to 
5 equivalents and prolonged reaction time did not increase the amount of difluorinated product 5k. 5k is 
an interesting product because it represents a C–H activation at the 8 position of the naphthalene resulting 
in a 6–member palladacyclic intermediate which then undergoes fluorination. 
The location of fluorination of the naphthalene substrate was done using cosy spectra. Using the 
2–dimensional NMR a confirmation on the location of the electrophilic fluorination could take place 
 
Figure 2: Cosy Spectra of fluorinated compound 5j  
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Entry Substrate Product Yield 
1 
  
100b (65) 
2 
  
97b (42) 
3 
  
27b (19) 
4 
  
63b (68) 
5 
  
47b (37) 
6 
  
46b (48) 
7 
  
19b (12) 
8 
  
17bc (23) 
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9 
  
100bc (92) 
9 
  
91b (88) 
  
 
(7) 
10 
  
0b 
11 
  
13b 
aReaction conditions; Substrate 4 (0.5 mmol), NFSI (1.5 equiv), Pd(NO3)2 (20 mol%), AgNO3 (50 
mol%) in MeCN at 80 oC for 24 h. bGCMS conversion using dodecane as internal standard. Percent of 
isolated yields in parenthesis. c2.5 equivalents NFSI 
 
Table 2: Palladium–catalyzed fluorination of aryl 4,4–dimethyloxazolines substituted arenes  
 
2–Dimensional NMR was also used in determing that fluorination of the m–tolyl substituted aryl 
oxazoline 5g was fluorinated in the less sterically hindered position.  
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Figure 3: 2–D Cosy proton proton NMR of compound 5g used in determing fluorination of the 
less sterically hindered postion 
 
The oxazoline was converted to the corresponding acid using a 2–step sequence.41 The treatment 
of 4c with methyl iodide followed by basic hydrolysis using NaOH afforded 2–fluorobenzoic acid 6 in 
77% in 2 steps (Scheme 4). 
 
Scheme 4: Removal of oxazoline directing group 
 
NO
F
4c
1. MeI, ACN, reflux,
    6 h, rt, 24 h
2. 20% NaOH, MeOH
    reflux, 6 h
    77%, 2 steps
OHO
F
6
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Many investigators have forwarded mechanistic insight for palladium catalyzed electrophilic C–H 
fluorination.30,32,43 Based on the experimental results reported above and compared to the results other 
groups have reported, a plausible mechanism is proposed based on Hierso’s catalytic cycle, which has 
been supported by experimental, and mass spectrometric analysis.32 As shown in Scheme 5, C–H 
activation of substrate 4a by Pd(NO3)2 assembles Pd(II) complex I. Ligand exchange between I and the 
second substrate 5a affords complex II. Oxidative addition of NFSI to II then produces Pd(IV) complex 
III, which undergoes reductive elimination to deliver fluorinated product 6a and Pd(II) complex IV. 
Another ligand exchange between IV and HNO3 then delivers Pd(II) complex I to continue the next 
catalytic cycle. 
 
Scheme 5: Proposed mechanism for the electrophilic fluorination 
2.3 Conclusion 
In conclusion we have reported an ortho directed palladium catalyzed electrophilic fluorination 
reaction using oxazoline as a removable directing group. The aryl substituents can efficiently promote the 
fluorination reaction and the reaction conditions are tolerant to chloro and bromo halides. The reaction 
conditions can be used for late stage fluorination, or the oxazoline can be hydrolyzed to give the 
corresponding acid. 
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Chapter 3: Appendix A  
3.1 General Methods 
All reactions were performed in anhydrous solvents under a N2 atmosphere. Solvents were 
purchased from Alfa Aesar and utilized without further purifications. Phenyl–2–oxazoline (1), 2–ethyl–2–
oxazoline (3), dibenzenesulfonimide, bistrifluoroacetamide, and dimethanesulfonimide are commercially 
available and were used without further purifications. Analytical thin–layer chromatography (TLC) 
was carried out using Silica G TLC plates, 200 µM with UV254 (SORBENT Technologies), with 
visualization by UV or iodine. Flash chromatography was performed using standard grade silica gel (60 
Å, 230–400 mesh; SORBENT Technologies). Melting Points were taken using Vernier Melt Station 
LabQuest 2 and were not corrected. NMR spectra were acquired using an Agilent VNMRS spectrometer 
equipped with one NMR probe (500 MHz for 1H, 125 MHz for 13C, 470 MHz for 19F). Spectra were 
processed using MNova software (Mestrelab). Chemical shifts are reported in parts per million (ppm), 
coupling constants (J) in Hz and are calibrated to residual protonated solvent. Infrared spectra of neat 
samples were acquired using a PerkinElmer Spectrum 100 FT–IR spectrometer, with solid samples 
analyzed using a Universal ATR (attenuated total reﬂectance) sampling accessory. GC–MS was 
performed on a Hewlett Packard HP6890 Series GC System and a 5973 Mass Selective Detector. 
3.2 Preparations of Aryl–2–oxazolines 
 
The following synthesis of 9 is exemplary of all oxazoline derivatives synthesized.  
2–Thiophene Carboxcylic acid (1 gram 7.8 mmol) was dissolved in 10mL of anhydrous methylene 
chloride and cooled to 0 oC; 5 drops of DMF was added to the suspension. Oxalyl chloride (1.98 grams 
15.8 mmol) was added drop wise to the reaction mixture. The reaction was warmed to room temperature 
and stirred for 3 h. The solvent was removed in vacuo and the residue was dried for 1 h on high vacuum. 
The residue was dissolved in 5mL of methylene chloride and added drop wise to a suspension of 
chloroethylamine•HCl (1.08 g 9.4 mmol), triethylamine (2.52g g 24 mmol) in 7mL of methylene chloride 
at 0 oC. The reaction stirred for 3 h and was warmed to room temperature. The reaction was diluted with 
O OH 1. (COCl)2, cat. DMF,
0 oC, CH2Cl2, 3hr
2. Then H2NCH2CH2Cl, Et3N,
0 oC, CH2Cl2
O
H
N Cl
O
H
N Cl 1. NaOH, 25 oC, EtOH NO
9
SS
S S
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methylene chloride and washed once with sat. aq. ammonium chloride and washed twice with brine. The 
organic layer was dried over MgSO4, filtered, then concentrated. The crude reaction mixture was purified 
by flash chromatography in a solvent system of hexane: ethyl acetate 2/1, respectively, to afford the 
amide intermediate. The thiophene amide intermediate (1.07 g 5.7 mmol) and sodium hydroxide (0.286g 
7.2 mmol) was added to a reaction flask dissolved in ethanol and heated to 50 oC for 1 hour. The reaction 
was diluted with ethyl acetate and washed twice with brine. The organic layer was dried over MgSO4, 
filtered, and then concentrated.  
3.3 Preparation of Sulfonimides 
 
The aryl–2–oxazoline substrate (0.30 mmol) was dissolved in 3 mL of 1,4–dioxane. After addition of 
sulfonimide (0.45 mmol), the resulting solution was refluxed for 30 min to 2 h until reaction was judged 
complete by TLC (hexane: ethyl acetate). The reaction was cooled, diluted with ethyl acetate, washed 
once with sat. aq. ammonium chloride, and twice with brine. The organic layer was concentrated in vacuo. 
The crude product was purified using flash chromatography (hexane: ethyl acetate) to obtain the desired 
ring opened product.  
3.4 Characterization of New Compounds 
 
2–(furan–3–yl)–4,5–dihydrooxazole  
Yellow oil (73% yield), m.p. 36– 39 oC; FTIR (neat, ATR, cm–1) 3091,1668, 1517, 1353, 1272, 1151, 
1113, 1063, 976, 927 869, 843, 750; 1H NMR (500 MHz, Chloroform–d) δ 7.88 (s, 1H), 7.43 (t, J = 1.7 
Hz, 1H), 6.76 (dd, J = 1.8, 0.8 Hz, 1H), 4.36 (t, J = 9.4 Hz, 2H), 3.99 (t, J = 9.4 Hz, 2H); 13C NMR (126 
MHz, cdcl3) δ 159.98, 144.77, 143.80, 115.68, 109.53, 67.42, 54.76; HRMS (ESI, m/z) calcd for 
C7H7N1O2: 137.0477, found: 137.0476. 
 
NO O
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3.5 Characterization data for Sulfonimides 
  
N–(2–(N–(Phenylsulfonyl)phenylsulfonamido)ethyl)benzamide  
White solid (93% yield), m.p. 81.2–83.3 oC; FTIR (neat, ATR, cm–1) 3312, 3071, 2990, 1725, 1737, 1642, 
1544, 1492 1448, 1371, 1353, 1160, 1169, 882, 825 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.00 (dd, 
J = 8.5, 1.3 Hz, 4H), 7.74 (dd, J = 8.2, 1.1 Hz, 2H), 7.65 – 7.56 (m, 2H), 7.53 – 7.43 (m, 5H), 7.41 – 7.34 
(m, 2H), 6.91 (s, 1H), 3.98 (t, J = 5.8 Hz, 2H), 3.72 (q, J = 5.6 Hz, 2H); 13C NMR (125 MHz, cdcl3) δ 
167.69, 139.19, 134.26, 133.98, 131.64, 129.34, 128.62, 128.28, 127.06, 47.51, 39.52; HRMS (ESI, m/z) 
calcd for C21H20N2O5S2: 444.0814, found: 444.0815. 
 
 
N–(2–(N–(Phenylsulfonyl)phenylsulfonamido)ethyl)propionamide  
White solid (75% yield), m.p. 113.3–119.5 oC; FTIR (neat, ATR, cm–1) 3274, 1644, 1539, 1447,1368, 
1166, 1083, 833 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 7.98 (dd, J = 8.4, 1.1 Hz, 4H), 7.70 – 7.63 
(m, 2H), 7.59 – 7.51 (m, 4H), 5.97 (s, 1H), 3.87 (t, J = 5.8 Hz, 2H), 3.54 (q, J = 5.7 Hz, 2H), 2.16 (q, J = 
7.6 Hz, 2H), 1.09 (t, J = 7.6 Hz, 3H); 13C NMR (126 MHz, cdcl3) δ 174.19, 139.21, 134.14, 129.24, 
128.24, 47.53, 38.80, 29.55, 9.58; HRMS (ESI, m/z) calcd for C17H20N2O5S2: 396.0814, found: 
396.08084. 
 
 
4–Methoxy–N–(2–(N–(phenylsulfonyl)phenylsulfonamido)ethyl)benzamide  
White solid (72% yield), m.p. 139.2–140.0 oC; FTIR (neat, ATR, cm–1) 3317, 1634, 1605, 1548, 
1447,1372, 1260, 1128, 1084, 883, 834 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.00 (d, J = 7.8 Hz, 
4H), 7.71 (d, J = 8.3 Hz, 2H), 7.62 (t, J = 7.5 Hz, 2H), 7.51 (t, J = 7.7 Hz, 4H), 6.89 (d, J = 8.4 Hz, 2H), 
6.76 (s, 1H), 3.97 (t, J = 5.7 Hz, 2H), 3.82 (s, 3H), 3.71 (q, J = 5.6 Hz, 2H); 13C NMR (126 MHz, cdcl3) δ 
H
NO N S
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O
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H
NO N S
S
O
OO
O
13
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NO N S
S
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OO
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167.22, 162.34, 139.26, 134.29, 129.38, 128.91, 128.33, 126.36, 113.85, 55.50, 47.62, 39.47; HRMS 
(ESI, m/z) calcd for C22H22N2O6S2: 474.0919, found: 474.0912. 
 
 
N–(2–(N–(Phenylsulfonyl)phenylsulfonamido)ethyl)thiophene–2–carboxamide  
White solid (93% yield), m.p. 117.3–119.8 oC; FTIR (neat, ATR, cm–1) 3270, 2259, 1626, 1563, 1448, 
1372, 1167, 1127, 1083, 870, 857, 809 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.02 (d, J = 7.2 Hz, 
4H), 7.67 – 7.62 (m, 2H), 7.54 (t, J = 7.9 Hz, 4H), 7.46 (dd, J = 5.0, 1.1 Hz, 1H), 7.43 (dd, J = 3.8, 1.2 
Hz, 1H), 7.04 (dd, J = 5.0, 3.7 Hz, 1H), 6.67 (s, 1H), 3.97 (t, J = 5.8 Hz, 2H), 3.71 (q, J = 5.5 Hz, 2H); 13C 
NMR (126 MHz, cdcl3) δ 162.21, 139.25, 138.75, 134.36, 130.31, 129.45, 128.38, 128.23, 127.79, 47.50, 
39.40; HRMS (ESI, m/z) calcd for C19H18N2O5S3: 450.0378, found: 450.0373. 
 
 
N–(2–(N–(Phenylsulfonyl)phenylsulfonamido)ethyl)thiophene–3–carboxamide  
White solid (94% yield), m.p. 145.1–145.9 oC; FTIR (neat, ATR, cm–1) 3294, 1633, 1551, 1448, 1369, 
1295, 1166, 1083, 861, 830 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.01 (d, J = 7.8 Hz, 4H), 7.83 (s, 
1H), 7.64 (t, J = 7.5 Hz, 2H), 7.53 (t, J = 7.7 Hz, 4H), 7.36 (d, J = 5.0 Hz, 1H), 7.30 (s, 1H), 6.70 (s, 1H), 
3.97 (t, J = 5.7 Hz, 2H), 3.70 (d, J = 5.7 Hz, 2H); 13C NMR (126 MHz, cdcl3) δ 163.30, 139.20, 137.19, 
134.35, 129.42, 128.56, 128.35, 126.55, 126.24, 47.54, 39.21; HRMS (ESI, m/z) calcd for C19H18N2O5S3: 
450.0378, found: 450.0372. 
 
 
N–(2–(N–(phenylsulfonyl)phenylsulfonamido)ethyl)furan–2–carboxamide  
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White solid (73% yield), m.p. 124.1–125.3 oC; FTIR (neat, ATR, cm–1) 3269, 1647, 1597, 1537, 1446, 
1368, 1350, 1323, 1300, 1177, 1167, 1129, 1077, 1010, 873, 810 cm-1; 1H NMR (500 MHz, Chloroform–
d) δ 8.05 – 7.99 (m, 4H), 7.67 – 7.61 (m, 2H), 7.57 – 7.49 (m, 4H), 7.42 (dd, J = 1.8, 0.8 Hz, 1H), 7.08 
(dd, J = 3.4, 0.8 Hz, 1H), 6.75 (s, 1H), 6.48 (dd, J = 3.5, 1.8 Hz, 1H), 3.96 (t, J = 6.1 Hz, 2H), 3.68 (q, J = 
6.0 Hz, 2H); 13C NMR (126 MHz, cdcl3) δ 158.75, 147.74, 144.28, 139.40, 134.24, 129.37, 128.39, 
114.46, 112.17, 47.70, 38.95; HRMS (ESI, m/z) calcd for C19H18N2O6S2: 434.0606, found: 434.0599 
 
 
N–(2–(N–(Phenylsulfonyl)phenylsulfonamido)ethyl)furan–3–carboxamide  
White solid (90% yield), m.p. 121.8–125.3 oC; FTIR (neat, ATR, cm–1) 3254, 2261, 1638, 1589, 1542, 
1449, 1373, 1350, 1169, 1127, 1084, 1024, 864 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.03 – 7.97 
(m, 4H), 7.89 (dd, J = 1.6, 0.9 Hz, 1H), 7.69 – 7.62 (m, 2H), 7.57 – 7.51 (m, 4H), 7.39 (t, J = 1.8 Hz, 1H), 
6.59 (dd, J = 1.9, 0.9 Hz, 1H), 6.52 (s, 1H), 3.95 (t, J = 5.4 Hz, 2H), 3.67 (q, J = 5.3 Hz, 2H); 13C NMR 
(126 MHz, cdcl3) δ 162.94, 144.97, 143.86, 139.20, 134.38, 129.44, 128.37, 122.38, 108.41, 47.50, 38.96; 
HRMS (ESI, m/z) calcd for C19H18N2O6S2: 434.0606, found: 434.0602. 
 
 
N–(2–(1,1,3,3–Tetraoxidobenzo[d][1,3,2]dithiazol–2–yl)ethyl)benzamide  
White solid (95% yield), m.p. 162–164 oC; FTIR (neat, ATR, cm–1) 3337, 1635, 1536, 1337, 1320, 1203, 
11,39, 1125, 1069, 947, 797, 761, 721 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.08 – 7.73 (m, 5H), 
7.55 – 7.32 (m, 3H), 6.81 (s, 1H), 4.06 (br. s, 2H), 3.91 (br. s, 2H); 13C NMR (126 MHz, cdcl3) δ 167.93, 
135.21, 135.14, 134.12, 131.77, 128.69, 127.23, 122.47, 42.03, 39.15; HRMS (ESI, m/z) calcd for, 
C15H14N2O5S2: 366.0344, found: 366.0340. 
 
 
N–(2–(1,1,3,3–Tetraoxidobenzo[d][1,3,2]dithiazol–2–yl)ethyl)propionamide  
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White solid (89% yield), m.p. 114–117 oC; FTIR (neat, ATR, cm–1) 3270, 1638, 1551, 1335, 1198, 1167, 
1091, 811, 764, 730 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.05 – 8.00 (m, 2H), 7.99 – 7.91 (m, 2H), 
6.04 (s, 1H), 4.00 – 3.86 (m, 2H), 3.78 – 3.55 (m, 2H), 2.27 (q, J = 7.6 Hz, 2H), 1.18 (t, J = 7.6 Hz, 3H); 
13C NMR (126 MHz, cdcl3) δ 174.45, 135.33, 135.11, 122.45, 42.17, 38.57, 29.72, 9.64; HRMS (ESI, 
m/z) calcd for, C11H14N2O5S2: 318.0344, found: 318.0339. 
 
 
N–(2–(1,1,3,3–tetraoxidobenzo[d][1,3,2]dithiazol–2–yl)ethyl)thiophene–2–carboxamide  
White solid (95% yield), m.p. 158–162 oC; FTIR (neat, ATR, cm–1) 3318, 1629, 1547, 1442, 1336, 1203, 
1138, 1072, 969, 788, 766, 723 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.07 – 8.00 (m, 2H), 7.98 – 
7.90 (m, 2H), 7.56 (dd, J = 3.8, 1.2 Hz, 1H), 7.48 (dd, J = 5.0, 1.1 Hz, 1H), 7.06 (dd, J = 5.0, 3.7 Hz, 1H), 
6.66 (s, 1H), 4.08 – 4.02 (m, 2H), 3.93 – 3.86 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 162.29, 138.56, 
135.22, 135.17, 130.53, 128.58, 127.79, 122.51, 42.10, 39.07; HRMS (ESI, m/z) calcd for, C13H12N2O5S3: 
371.9908, found: 371.9903. 
 
 
N–(2–(1,1,3,3–tetraoxidobenzo[d][1,3,2]dithiazol–2–yl)ethyl)furan–2–carboxamide  
White solid (80% yield), m.p. 108–110 oC; FTIR (neat, ATR, cm–1) 3314, 1647, 1569, 1532, 1443, 1336, 
1202, 1140, 1075, 1046, 1021, 794, 753, 727 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.05 – 7.99 (m, 
2H), 7.97 – 7.88 (m, 2H), 7.44 (dd, J = 1.8, 0.8 Hz, 1H), 7.13 (dd, J = 3.5, 0.8 Hz, 1H), 6.91 (s, 1H), 6.48 
(dd, J = 3.5, 1.7 Hz, 1H), 4.03 – 3.99 (m, 2H), 3.92 – 3.86 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 158.80, 
147.70, 144.44, 135.29, 135.11, 122.51, 114.77, 112.20, 41.92, 38.28; HRMS (ESI, m/z) calcd for, 
C13H12N2O6S2: 356.0137, found: 356.0131. 
 
 
N–(2–(N–(Methylsulfonyl)methylsulfonamido)ethyl)benzamide  
White solid (56%). m.p. 167–169 oC; FTIR (neat, ATR, cm–1) 3271, 1628, 1543, 1353, 1152, 1068, 967, 
900, 795, 759, 671 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 7.82 (d, J = 7.6 Hz, 2H), 7.51 (t, J = 7.3 
Hz, 1H), 7.45 (t, J = 7.6 Hz, 2H), 6.61 (s, 1H), 4.05 (t, J = 5.5 Hz, 2H), 3.79 (q, J = 5.6 Hz, 2H), 3.33 (s, 
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6H); 13C NMR (126 MHz, cdcl3) δ 168.13, 134.05, 131.90, 128.85, 127.10, 47.32, 43.84, 38.93; HRMS 
(ESI, m/z) calcd for, C11H16N2O5S2: 320.0501, found: 320.0498. 
 
 
4–Methoxy–N–(2–(N–(methylsulfonyl)methylsulfonamido)ethyl)benzamide  
White solid (62%), m.p. 128–130 oC; FTIR (neat, ATR, cm–1) 3218, 1626, 1605, 1507, 1344, 1324, 1256, 
1153,1071, 1028, 961, 851, 802, 786, 757 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 7.80 – 7.78 (m, 
1H), 7.78 – 7.76 (m, 1H), 6.94 – 6.93 (m, 1H), 6.92 – 6.90 (m, 1H), 6.56 (s, 1H), 4.03 (t, J = 5.4 Hz, 2H), 
3.84 (s, 3H), 3.76 (q, J = 5.5 Hz, 2H), 3.32 (s, 6H); 13C NMR (126 MHz, cdcl3) δ 167.60, 162.52, 128.94, 
126.30, 114.03, 55.54, 47.37, 43.81, 38.88; HRMS (ESI, m/z) calcd for, C12H18N2O6S2: 350.0606, found: 
350.0600. 
 
 
N–(2–(N–(Methylsulfonyl)methylsulfonamido)ethyl)thiophene–3–carboxamide  
White solid (70%). m.p. 197–199 oC; FTIR (neat, ATR, cm–1) 3249, 1619, 1546, 1350, 1309, 1151, 1073, 
959, 893, 790, 698 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 7.54 (dd, J = 3.8, 1.1 Hz, 1H), 7.50 (dd, J 
= 4.9, 1.2 Hz, 1H), 7.09 (dd, J = 5.0, 3.7 Hz, 1H), 6.47 (s, 1H), 4.03 (t, J = 5.4 Hz, 2H), 3.76 (q, J = 5.6 
Hz, 2H), 3.33 (s, 6H); 13C NMR (126 MHz, cdcl3) δ 162.54, 138.48, 130.61, 128.49, 127.93, 47.18, 43.84, 
38.95. HRMS (ESI, m/z) calcd for, C9H14N2O5S3: 326.0065, found: 326.0062. 
 
 
N–(2–(N–(methylsulfonyl)methylsulfonamido)ethyl)furan–2–carboxamide  
White solid (61%), m.p. 166–169 oC; FTIR (neat, ATR, cm–1) 3235, 1641, 1569, 1538, 1352, 1319, 1153 
1073, 959, 868, 794 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 7.47 (dd, J = 1.8, 0.8 Hz, 1H), 7.12 (dd, J 
= 3.5, 0.8 Hz, 1H), 6.72 (s, 1H), 6.50 (dd, J = 3.5, 1.7 Hz, 1H), 4.00 (t, J = 6.2 Hz, 2H), 3.74 (q, J = 5.8 
Hz, 2H), 3.33 (s, 6H); 13C NMR (126 MHz, cdcl3) δ 158.98, 147.62, 144.54, 114.80, 112.28, 47.25, 43.67, 
38.54; HRMS (ESI, m/z) calcd for, C9H14N2O6S2: 310.0293, found: 310.0289. 
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N–(2–(N–(Methylsulfonyl)phenylsulfonamido)ethyl)benzamide  
White solid (84%), m.p. 138–141 oC; FTIR (neat, ATR, cm–1) 3364, 1643, 1541, 1369, 1362, 1314, 1290, 
1152, 1086, 976, 899, 791, 781, 723 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.05 – 7.99 (m, 2H), 
7.85 – 7.79 (m, 2H), 7.68 – 7.61 (m, 1H), 7.58 – 7.47 (m, 3H), 7.47 – 7.40 (m, 2H), 6.79 (s, 1H), 3.98 (d, 
J = 6.0 Hz, 2H), 3.75 (q, J = 5.5 Hz, 2H), 3.42 (s, 3H); 13C NMR (126 MHz, cdcl3) δ 167.93, 138.75, 
134.45, 134.03, 131.83, 129.41, 128.80, 128.39, 127.11, 47.37, 44.95, 39.22; HRMS (ESI, m/z) calcd for, 
C16H18N2O5S2: 382.0657, found: 382.0653 
 
 
N–(2–(N–(Methylsulfonyl)phenylsulfonamido)ethyl)propionamide  
White solid (78%), m.p, 130–133 oC; FTIR (neat, ATR, cm–1) 3282, 1647, 1539, 1448, 1431, 1360, 1346, 
1164, 1070, 964, 900, 796, 725, 681 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.01 (dd, J = 8.4, 1.2 Hz, 
2H), 7.69 – 7.64 (m, 1H), 7.59 – 7.53 (m, 2H), 5.88 (s, 1H), 3.85 (t, J = 5.7 Hz, 2H), 3.56 (q, J = 5.6 Hz, 
2H), 3.43 (s, 3H), 2.24 (q, J = 7.6 Hz, 2H), 1.16 (t, J = 7.6 Hz, 3H); 13C NMR (126 MHz, cdcl3) δ 174.49, 
138.94, 134.40, 129.40, 128.41, 47.55, 44.89, 38.48, 29.90, 9.82; HRMS (ESI, m/z) calcd for, 
C12H18N2O5S2: 334.0657, found: 334.0653 
 
 
N–(2–(N–(methylsulfonyl)phenylsulfonamido)ethyl)thiophene–2–carboxamide  
White solid (70%), m.p. 123–125 oC; FTIR (neat, ATR, cm–1) 3269, 1610.1549, 1361, 1347, 1320, 1265, 
1085, 1065, 967, 895, 853, 819, 783, 735, 728 cm-1; 1H NMR (500 MHz, Chloroform–d) δ 8.02 (dd, J = 
8.7, 1.5 Hz, 2H), 7.68 – 7.61 (m, 1H), 7.57 – 7.50 (m, 3H), 7.48 (dd, J = 5.0, 1.1 Hz, 1H), 7.07 (dd, J = 
5.0, 3.7 Hz, 1H), 6.71 (s, 1H), 3.95 (t, J = 5.7 Hz, 2H), 3.71 (q, J = 5.5 Hz, 2H), 3.42 (s, 3H); 13C NMR 
(126 MHz, cdcl3) δ 162.28, 138.52, 138.49, 134.31, 130.36, 129.27, 128.25, 128.24, 127.74, 47.08, 44.81, 
39.07; HRMS (ESI, m/z) calcd for, C14H16N2O5S3: 388.0221, found: 388.0218. 
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N–(2–(N–(Methylsulfonyl)phenylsulfonamido)ethyl)furan–3–carboxamide  
White solid (70%), m.p. 123–125 oC; FTIR (neat, ATR, cm–1) 3254, 3150, 1637, 1585, 1539, 1449, 1361, 
1348, 1338, 1318, 1128, 1088, 1069, 1031, 965, 873, 809, 753, 725, 682, 674 cm-1; 1H NMR (500 MHz, 
Chloroform–d) δ 8.00 (d, J = 7.4 Hz, 2H), 7.96 (s, 1H), 7.65 (t, J = 7.5 Hz, 1H), 7.54 (t, J = 7.8 Hz, 2H), 
7.42 (s, 1H), 6.66 (d, J = 1.9 Hz, 1H), 6.55 (s, 1H), 3.92 (t, J = 5.7 Hz, 2H), 3.67 (q, J = 5.5 Hz, 2H), 3.41 
(s, 3H); 13C NMR (126 MHz, cdcl3) δ 163.13, 145.06, 143.97, 138.66, 134.46, 129.41, 128.35, 122.37, 
108.41, 47.24, 44.92, 38.66; HRMS (ESI, m/z) calcd for, C14H16N2O6S2:372.0450, found: 372.0446. 
 
3.6 Characterization of known Compounds 
 
 
2–(4–methoxyphenyl)–4,5–dihydrooxazole  
White solid, m.p. 40.8–42.3 oC; FTIR (neat, ATR, cm–1) 1644, 1606, 1510, 1253, 1166, 1068, 1021, 939, 
844, 672; 1H NMR (500 MHz, Chloroform–d) δ 7.88 (d, J = 8.9 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 4.39 (t, 
J = 9.5 Hz, 2H), 4.02 (t, J = 9.4 Hz, 2H), 3.83 (s, 3H); 13C NMR (126 MHz, cdcl3) δ 162.15, 129.99, 
128.94, 120.35, 113.80, 67.64, 55.45, 54.92. 
 
 
2–(thiophen–2–yl)–4,5–dihydrooxazole  
White solid, m.p. 59–60 oC; FTIR (neat, ATR, cm–1) 1643, 1430, 1246, 1051, 1013, 925, 851, 729, 692; 
1H NMR (500 MHz, Chloroform–d) δ 7.58 (dd, J = 3.6, 1.2 Hz, 1H), 7.44 (dd, J = 5.0, 1.2 Hz, 1H), 7.07 
(dd, J = 5.0, 3.7 Hz, 1H), 4.42 (t, J = 9.4 Hz, 2H), 4.03 (t, J = 9.4 Hz, 2H); 13C NMR (126 MHz, cdcl3) δ 
160.51, 130.49, 130.25, 129.83, 127.68, 68.16, 55.12. 
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2–(thiophen–3–yl)–4,5–dihydrooxazole  
White solid, m.p. 73–74 oC; FTIR (neat, ATR, cm–1) 3107, 3070, 1651, 1421, 1317, 1258, 1064, 951, 702; 
1H NMR (500 MHz, Chloroform–d) δ 7.87 (d, J = 3.3 Hz, 1H), 7.51 (d, J = 5.1 Hz, 1H), 7.31 (dd, J = 5.1, 
3.0 Hz, 1H), 4.38 (t, J = 9.4 Hz, 2H), 4.02 (t, J = 9.5 Hz, 2H); 13C NMR (126 MHz, cdcl3) δ 161.16, 
130.06, 128.66, 127.30, 126.24, 67.55, 54.91. 
 
 
2–(furan–2–yl)–4,5–dihydrooxazole  
White solid, m.p. 76–79 oC; FTIR (neat, ATR, cm–1) 3099, 1673, 1563, 1480, 1352, 1172, 1096, 1013, 
954, 774, 706 cm–1; 1H NMR (500 MHz, Chloroform–d) δ 7.54 (dd, J = 1.8, 0.8 Hz, 1H), 6.94 (d, J = 3.4 
Hz, 1H), 6.48 (dd, J = 3.5, 1.8 Hz, 1H), 4.41 (t, J = 9.6 Hz, 2H), 4.06 (t, J = 9.4 Hz, 2H); 13C NMR (126 
MHz, cdcl3) δ 157.09, 145.26, 143.24, 114.27, 111.60, 67.87, 55.04. 
 
 
N–(phenylsulfonyl)acetamide  
White solid, m.p. 128–131 oC; FTIR (neat, ATR, cm–1) 3112, 2902, 1702, 1686, 1459, 1352, 1160, 1090, 
934, 858, 762, 687 cm–1; 1H NMR (500 MHz, Chloroform–d) δ 9.38 (s, 1H), 8.11 – 7.99 (m, 2H), 7.68 – 
7.60 (m, 1H), 7.57 – 7.51 (m, 2H), 2.07 (s, 3H); 13C NMR (126 MHz, cdcl3) δ 169.00, 138.54, 134.17, 
129.16, 128.29, 23.60. 
 
 
 
 
2,2,2–trifluoro–N–(phenylsulfonyl)acetamide  
White solid, m.p. 139–142 oC; FTIR (neat, ATR, cm–1) 3223, 1772, 1467, 1360, 1154, 1116, 1081, 887, 
826, 757, 679 cm–1; 1H NMR (500 MHz, Chloroform–d) δ 8.79 (br. s, 1H), 8.14 – 8.10 (m, 2H), 7.78 – 
NO
10S
NO
11
O
H
N S
O
O
O
23
H
N S
O
O
O
24F F F
	33 
7.71 (m, 1H), 7.65 – 7.56 (m, 2H); 13C NMR (126 MHz, cdcl3) δ 154.20, 153.87, 136.88, 135.38, 129.57, 
128.97; 19F NMR (470 MHz, cdcl3) δ –75.64. 
 
 
N–(methylsulfonyl)benzenesulfonamide  
White solid, m.p. 138–142 oC; FTIR (neat, ATR, cm–1) 3210, 1453, 1348, 1088, 973, 864, 758 cm–1; 1H 
NMR (500 MHz, Chloroform–d) δ 8.02 – 7.98 (m, 2H), 7.70 – 7.64 (m, 1H), 7.59 – 7.54 (m, 2H), 3.38 (s, 
3H); 13C NMR (126 MHz, cdcl3) δ 139.25, 134.44, 129.38, 128.11, 44.16. 
 
3.7 Copies of NMR Spectra of New Compounds 
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3.8 Copies of NMR for New Sulfonimides 
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3.9 Copies of NMR’s for Known Compounds 
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Chapter 4: Appendix B 
4.1 General Methods 
All reactions were performed in anhydrous solvents under a N2 atmosphere. Solvents were purchased 
from Alfa Aesar and utilized without further purifications. Analytical thin–layer chromatography 
(TLC) was carried out using Silica G TLC plates, 200 mM with UV254 (SORBENT Technologies), with 
visualization by UV or iodine. Flash chromatography was performed using standard grade silica gel (60 
Å, 230–400 mesh; SORBENT Technologies). Melting Points were taken using Vernier Melt Station 
LabQuest 2 and were not corrected. NMR spectra were acquired using an Agilent VNMRS spectrometer 
equipped with one NMR probe (500 MHz for 1H, 125 MHz for 13C, 470 MHz for 19F). Spectra were 
processed using MNova software (Mestrelab). Chemical shifts are reported in parts per million (ppm), 
coupling constants (J) in Hz and are calibrated to residual protonated solvent. Infrared spectra of neat 
samples were acquired using a PerkinElmer Spectrum 100 FT–IR spectrometer, with solid samples 
analyzed using a Universal ATR (attenuated total reﬂectance) sampling accessory. GC–MS was 
performed on a Hewlett Packard HP6890 Series GC System and a 5973 Mass Selective Detector. 
4.2 General Procedures for Fluorination 
As a typical experiment, the oxazoline derivative 5 (0.5 mmol), NFSI (X mmol), Pd(NO3)2 (0.1 mmol), 
and AgNO3 (0.25 mmol) were charged into an oven dried reaction vial, equipped with a magnetic stirring 
bar and sealed. The reaction vial was evacuated and purged several times with nitrogen. Anhydrous 
acetonitrile (5 mL) was added, and the microwave vial purged several times with nitrogen. The 
microwave vial was placed in a heating block at 80°C and reactants were allowed to stir for 24 hr. After 
cooling to room temperature, the reaction mixture was filtered through a plug of silica, using ethyl acetate 
and then washed twice with 3% triethylamine in water solution, twice with brine and then the organic 
layer was dried over MgSO4 and filtered. The organic layer was concentrated in vacuo and the residue 
and was analyzed by gas chromatography using dodecane as an internal standard to determine the 
conversion of the fluorinated product. The crude product was purified by silica gel column 
chromatography using an appropriate ratio of the eluent. 
4.3 General Procedures for Preparations of Aryl–2–oxazolines 
 
	62 
Aryl acid (10 mmol) was dissolved in 20 mL of dried methylene chloride and cooled to 0oC; 5 drops of 
DMF was added to the suspension. Oxalyl chloride (12 mmol) was added drop wise to the reaction 
mixture. The reaction was warmed to room temperature and stirred for 3 h. The solvent was removed in 
vacuo and the residue was dried for 1 h on high vacuum. The residue was dissolved in 15mL of 
methylene chloride and added drop wise to a suspension of 2–amino–2–methyl–1–propanol (1.39 g, 12 
mmol), triethylamine (2.02 g, 20 mmol) in 35 mL of methylene chloride at 0oC. The reaction stirred for 3 
h and was warmed to rt. The reaction was diluted with methylene chloride and washed once with dilute 
HCl and washed twice with brine. The organic layer was dried, (MgSO4) filtered, and concentrated in 
vacuo to give the crude amide intermediate. The crude amide intermediate (2.07 g 10 mmol) was 
dissolved in 50 mL of DCM and triethylamine (1.21 g, 12 mmol) was added. The reaction was stirred for 
30 min at 0oC. Mesylchloride (1.37 g, 12 mmol) was added drop wise and the reaction warmed to room 
temperature and stirred for 3 h. The reaction was diluted with DCM and washed twice with dilute HCl 
and twice with brine. The organic layer was was dried, (MgSO4) filtered, and concentrated in vacuo to 
give the crude mesylate intermediate. The crude mesylate product was purified via flash chromatography 
in a gradient of hexane ethyl acetate respectively. The purified product was then diluted in 20 mL of 
ethanol and sodium hydroxide (480 mg, 9.3 mmol) was added and the reaction was stirred for 30 min. 
The reaction mixture was diluted with ethyl acetate and washed 3 times with brine. The organic layer was 
dried over MgSO4 filtered and concentrated in vacuo to afford the product after flash chromatography.  
4.4 Procedure for Removal of Directing group. 
To a solution of the 2–(2–Fluorophenyl)–4,4–dimethyl–4,5–dihydrooxazole (6b) (38 mg, 0.2 mmol) in 
CH3CN (3 mL) was added methyl iodide (1 mL, 16 mmol) and the mixture was heated to reflux for 6 h. 
The reaction mixture was then cooled to room temperature and stirred overnight. The reaction mixture 
was concentrated and the residue was triturated with Et2O. Methanol (3 mL) was added to the residue. 
NaOH (80 mg, 2 mmol) and heated to reflux for 6 h. The reaction mixture was cooled to room 
temperature and concentrated. The aqueous phase was washed several times with DCM, and then acidfied 
to pH 1 using 1M HCl. The aqueous phase was extracted with twice with DCM. The combined organic 
phase was washed with brine, dried (MgSO4) and concentrated to afford 22 mg (77%) of the benzoic acid, 
as an off white solid. 
4.5 Screening of Fluorination Conditions  
4.5.1 Screening of Fluorinating agents 
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Entry Fluorine Source %SM %Fluorination 
1 A 72 28 
2 B 87 13 
3 C 100 0 
4 D 100 0 
5 E 100 0 
6 F 100 0 
a Reaction conditions(0.1 mmol), [Pd] (20 mol%), [F+] (0.15 mmol), trifluoracetic acid (0.5 mmol) DMF 
(1 mL), 150 °C, under nitrogen, 24 h. b GCMS conversion using dodecane as internal standard. 
 
 
4.5.2 Screening of Palladium Catalysts 
 
Entry Pd Catalyst %SM %Fluorinationb 
1 Pd(TFA)2 71 29 
2 Pd(dba)2 90 10 
3 PdCl2 NR 0 
NO
H
NO
F
Pd(OAc)2 20 mol%
[F+] 1.5 eq.
TFA 5 eq.
DMF, 150 oC
NO
H
NO
F
(Pd) (20 mol%)
[NFSI] (1.5 eq)
TFA (5 eq)
DMF, 150 oC
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4 Pd(OTf)2 82 18 
5 Pd(PPh3)4 66 34 
6 Pd(NO3)2 60 40 
a Reaction conditions(0.1 mmol), [Pd] (20 mol%), NFSI (0.15 mmol), trifluoracetic acid (0.5 mmol) DMF 
(1 mL), 150 °C, under nitrogen, 24 h. b GCMS conversion using dodecane as internal standard. 
 
4.5.3 Screening of Nitrate salts 
 
Entry Nitrate Salt %SM %Fluorination 
1 AgNO3 53 47 
2 Ca(NO3)2 89 11 
3 KNO3 92 8 
4 Cu2(NO3) 83 17 
5 Na(NO3) 93 7 
a Reaction conditions(0.1 mmol), Pd(NO3)2 (20 mol%), NFSI (0.15 mmol), Nitrate salt (0.5 mmol) DMF 
(1 mL), 150 °C, under nitrogen, 24 h. b GCMS conversion using dodecane as internal standard. 
 
4.5.4 Additive loading  
 
Entry Eq AgNO3 %SM %Fluorination 
1 5 53 47 
2 2 52 48 
3 0.5 51 49 
4 0 100 0 
a Reaction conditions (0.1 mmol), Pd(NO3)2 (20 mol%), NFSI (0.15 mmol), AgNO3 (X mmol) DMF (1 
mL), 150 °C, under nitrogen, 24 h. b GCMS conversion using dodecane as internal standard. 
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4.5.5 Solvent Screening 
 
Entry Solvent Temperature oC %SM %Fluorination 
1 Acetonitrile 80 0 100 
2 Dioxane 100 84 16 
3 DMF 150 51 49 
4 CF3–toluene 80 91 9 
5 Nitromethane 100 21 71 
6 Dichloroethane 80 66 33 
7c THF 65 0 0 
8 NMP 150 73 27 
9 EtOAc 75 100 0 
10 DMSO 150 55 45 
a Reaction conditions(0.1 mmol), Pd(OAc)2 (20 mol%), NFSI (0.15 mmol), AgNO3 (50 mol%) Solvent (1 
mL), 150 °C, under nitrogen, 24 h. b GCMS conversion using dodecane as internal standard. c Starting 
material decomposition  
 
4.5.6 Screening of other Additives  
 
Entry Promoter %SM %Fluorination 
1 TFA 72 28 
2 Pivalic Acid 96 4 
3 Triflic Acid 95 5 
4 Dichloroacetic acid 84 16 
5 Chlorodifluorocacetic 
acid 
83 17 
6 Mesic acid 82 18 
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7 Tosic Acid 100 0 
8 Difluoroacetic acid 81 19 
14 L–Proline 100 0 
15 NMP 100 0 
a Reaction conditions(0.1 mmol), Pd(OAc)2 (20 mol%), NFSI (0.15 mmol), AgNO3 (50 mol%) Solvent (1 
mL), 150 °C, under nitrogen, 24 h. b GCMS conversion using dodecane as internal standard.  
 
4.5.7 Acid additive loading  
 
Entry Eq TFA %SM %Fluorination 
1 10 86 14 
2 5 72 28 
3 2 89 11 
4 0.5 91 9 
5 0 100 0 
a Reaction conditions(0.1 mmol), Pd(OAc)2 (20 mol%), NFSI (0.15 mmol), Trifluoroacetic acid (X mmol) 
DMF (1 mL), 150 °C, under nitrogen, 24 h. b GCMS conversion using dodecane as internal standard. 
 
4.6 Characterization of Fluorinated Compounds 
 
    
2–(2–Fluoro–6–methylphenyl)–4,4–dimethyl–4,5–dihydrooxazole (6a) 
Yellow oil 68 mg, 65% yield; Flash chromatography solvent system Et2O/Hex (1:1) Rf = 0.52; 1H NMR 
(500 MHz, CDCl3) δ 7.29 – 7.23 (m, 1H), 7.00 (d, J = 7.7 Hz, 1H), 6.93 (t, J = 8.9 Hz, 1H), 4.13 (s, 2H), 
2.41 (s, 3H), 1.43 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 161.01 (d, J = 250.4 Hz), 158.70, 140.03 (d, J = 
2.2 Hz), 131.18 (d, J = 9.1 Hz), 125.83 (d, J = 3.2 Hz), 113.11 (d, J = 21.5 Hz), 79.24, 68.16, 28.47, 19.62 
(d, J = 2.3 Hz); 19F NMR (470 MHz, CDCl3) δ –114.12; HRMS–ESI (m/z): calcd for C12H14FNO (M+H): 
207.1059, found 
 
 
 
NO
H
NO
F
Pd(OAc)2 (20 mol%)
[NFSI] (1.5 eq)
TFA (X eq)
DMF, 150 oC
	67 
 
2–(2–Fluorophenyl)–4,4–dimethyl–4,5–dihydrooxazole (6b) 
White solid, 44 mg, 46% yield; Flash chromatography solvent system Et2O/Hex (1:4) Rf = 0.26; 1H NMR 
(500 MHz, CDCl3) δ 7.95 – 7.81 (m, 1H), 7.50 – 7.39 (m, 1H), 7.20 – 7.08 (m, 2H), 4.11 (s, 2H), 1.41 (s, 
6H); 13C NMR (126 MHz, CDCl3) δ 161.19 (dd, J = 257.6, 2.9 Hz), 159.15 (d, J = 12.3 Hz), 133.59 – 
132.40 (m), 131.49 – 131.02 (m), 124.01 (t, J = 3.3 Hz), 116.71 (dd, J = 22.1, 3.0 Hz), 79.02 (d, J = 7.9 
Hz), 67.82, 28.44; 19F NMR (470 MHz, CDCl3) δ –109.49; 
 
 
 
2–(2–Fluoro–6–methoxyphenyl)–4,4–dimethyl–4,5–dihydrooxazole (6c) 
Clear oil; 47 mg, 42% yield; Flash chromatography solvent system EtOAc/Hex (1:3) Rf = 0.42; 1H NMR 
(500 MHz, CDCl3) δ 7.32 (td, J = 8.5, 6.5 Hz, 1H), 6.76 – 6.65 (m, 2H), 4.13 (s, 2H), 3.85 (s, 3H), 1.42 
(s, 6H); 13C NMR (126 MHz, CDCl3) δ 161.51 (d, J = 250.7 Hz), 159.28 (d, J = 6.5 Hz), 156.43, 131.84 
(d, J = 10.6 Hz), 108.17 (d, J = 21.9 Hz), 106.79 (d, J = 3.1 Hz), 79.14, 68.11, 56.54, 28.41; 19F NMR 
(470 MHz, CDCl3) δ –112.49; HRMS–ESI (m/z): calcd for C12H14FNO2 (M+H): 223.1009, found 
 
 
 
2–(2–Chloro–6–fluorophenyl)–4,4–dimethyl–4,5–dihydrooxazole (4d) 
Yellow oil, 77 mg, 68% yield; Flash chromatography solvent system Et2O/Hex (1:1) Rf = 0.61; 1H NMR 
(500 MHz, CDCl3) δ 7.36 – 7.28 (m, 1H), 7.24 – 7.20 (m, 1H), 7.07 – 6.99 (m, 1H), 4.16 (s, 2H), 1.43 (s, 
6H); 13C NMR (126 MHz, CDCl3) δ 161.09 (d, J = 254.2 Hz), 156.31, 134.73 (d, J = 4.1 Hz), 132.51 – 
131.04 (m), 125.51 (d, J = 3.9 Hz), 118.32 (d, J = 18.8 Hz), 114.40 (d, J = 21.5 Hz), 79.56 (d, J = 6.2 
Hz), 68.56, 28.29; 19F NMR (470 MHz, CDCl3) δ –110.68; HRMS–ESI (m/z): calcd for C11H11ClFNO 
(M+H): 227.0513, found 
 
 
2–(2–bromo–6–fluorophenyl)–4,4–dimethyl–4,5–dihydrooxazole 
Yellow oil 47 mg, 37% yield; Flash chromatography solvent system Et2O/Hex (1:4) Rf = 0.38; 1H NMR 
(500 MHz, CDCl3) δ 7.40 (dd, J = 8.1, 1.1 Hz, 1H), 7.30 – 7.22 (m, 1H), 7.08 (t, J = 8.7 Hz, 1H), 4.16 (s, 
2H), 1.44 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 160.93 (d, J = 255.0 Hz), 157.31, 132.20 (dd, J = 9.6, 
3.1 Hz), 128.60 (d, J = 3.6 Hz), 123.21 (d, J = 3.3 Hz), 114.94 (d, J = 21.4 Hz), 79.65, 68.60, 28.25; 19F 
NMR (470 MHz, CDCl3) δ –110.01; HRMS (ESI, m/z) calcd for C11H12BrNO, 253.0102; found: 
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2–(2,6–Difluorophenyl)–4,4–dimethyl–4,5–dihydrooxazole (6e) 
Clear oil, 20 mg, 19% yield. Flash chromatography solvent system Et2O/Hex (1:4) Rf = 0.32. 1H NMR 
(500 MHz, CDCl3) δ 7.46 – 7.31 (m, 1H), 7.00 – 6.80 (m, 2H), 4.12 (s, 2H), 1.41 (s, 6H); 13C NMR (126 
MHz, CDCl3) δ 161.26 (dd, J = 255.6, 6.2 Hz), 154.65, 132.17 (t, J = 10.4 Hz), 111.90 (dd, J = 20.8, 4.5 
Hz), 107.77 (t, J = 17.9 Hz), 79.20, 68.30, 28.38; 19F NMR (470 MHz, CDCl3) δ –109.58, –109.59, –
109.59, –109.61. 
 
 
2–(2–Fluoro–5–methylphenyl)–4,4–dimethyl–4,5–dihydrooxazole (6x)  
Clear oil, 13 mg, 12% yield. Flash chromatography solvent system Et2O/Hex (1:4) Rf = 0.21. 1H NMR 
(500 MHz, CDCl3) δ 7.76 – 7.65 (m, 1H), 7.22 (dd, J = 8.2, 4.0 Hz, 1H), 7.01 (dd, J = 10.6, 8.5 Hz, 1H), 
4.12 (s, 2H), 2.33 (s, 3H), 1.41 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 159.84, 159.31 (d, J = 254.9 Hz), 
133.57, 131.36, 116.42, 116.25, 79.21, 71.81, 67.24, 28.24, 20.40; 19F NMR (470 MHz, CDCl3) δ –
114.85; HRMS–ESI (m/z): calcd for C12H14FNO (M+H): 207.1059, found 
 
 
2–(2–Fluoronaphthalen–1–yl)–4,4–dimethyl–4,5–dihydrooxazole 
White solid, 106 mg, 88% yield; Flash chromatography solvent system EtOAc/Hex (1:1) Rf = 0.43; 1H 
NMR (500 MHz, CDCl3) δ 7.95 (d, J = 8.4 Hz, 1H), 7.75 – 7.62 (m, 2H), 7.52 (t, J = 7.7 Hz, 1H), 7.49 – 
7.40 (m, 1H), 7.24 – 7.17 (m, 1H), 4.25 (s, 2H), 1.49 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 164.54, 
158.40 (d, J = 253.6 Hz), 135.43 (d, J = 4.2 Hz), 130.42 (d, J = 3.1 Hz), 129.09, 126.43 (d, J = 8.6 Hz), 
125.91, 124.50 (d, J = 4.1 Hz), 123.44, 121.35 (d, J = 13.6 Hz), 111.94 (d, J = 21.9 Hz), 80.27, 67.81, 
28.19; 19F NMR (470 MHz, CDCl3) δ –76.02, –113.74, –113.75, –113.77, –113.77, –113.78; HRMS (ESI, 
m/z) calcd for C15H14FNO 243.1059; found: 
 
 
2–(2,8–Difluoronaphthalen–1–yl)–4,4–dimethyl–4,5–dihydrooxazole 
Yellow solid, 8 mg, 6% yield. Flash chromatography solvent system EtOAc/Toluene (1:4) Rf = 0.29; 1H 
NMR (500 MHz, CDCl3) δ 8.21 (dd, 1H), 7.90 (d, J = 8.3 Hz, 1H), 7.78 (d, J = 7.7 Hz, 1H), 7.66 – 7.59 
(m, 1H), 7.47 – 7.36 (m, 1H), 3.98 (s, 2H), 1.65 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 170.21, 169.11 
(d, J = 213.5 Hz), 161.06, 158.21 (d, J = 261.3 Hz), 138.71 (d, J = 5.3 Hz), 135.61 (d, J = 2.4 Hz), 
133.55, 129.35, 129.20 (d, J = 7.9 Hz), 126.60, 126.00 (d, J = 22.3 Hz), 125.40 (d, J = 4.6 Hz), 124.44 (d, 
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J = 3.9 Hz), 119.30, 114.84 (d, J = 21.6 Hz), 111.71 (d, J = 21.1 Hz), 69.85, 68.53, 62.49, 53.96, 29.85, 
23.42; 19F NMR (470 MHz, CDCl3) δ –102.17, –102.18, –102.20, –102.21; HRMS (ESI, m/z) calcd for 
C15H13F2NO 261.0965; found : 
 
 
 
2–(2,6–difluoro–4–methoxyphenyl)–4,4–dimethyl–4,5–dihydrooxazole 
Yellow oil 110 mg, 92% yield. Flash chromatography solvent system Et2O/Hex (1:1) Rf = 0.36; 1H NMR 
(500 MHz, CDCl3) δ 6.50 (d, J = 10.1 Hz, 2H), 4.14 (s, 2H), 3.82 (s, 3H), 1.44 (s, 6H); 13C NMR (126 
MHz, CDCl3) δ 162.15 (dd, J = 255.0, 9.2 Hz), 105.66 – 95.31 (m), 71.83, 67.42, 55.99, 28.09; 19F NMR 
(470 MHz, CDCl3) δ –106.75, –106.77; HRMS (ESI, m/z) calcd for C12H13F2NO2, 241.0914; found: 
 
 
2–(2–fluoro–4–methylphenyl)–4,4–dimethyl–4,5–dihydrooxazole 
Clear oil 18 mg, 17% yield. Flash chromatography solvent system Et2O/Hex (1:4) Rf= 0.19; 1H NMR (500 
MHz, CDCl3) δ 7.79 (s, 1H), 6.96 (dd, J = 18.5, 9.9 Hz, 2H), 4.11 (s, 2H), 2.37 (s, 2H), 1.41 (s, 6H); 13C 
NMR (126 MHz, CDCl3) δ 161.86, 161.04 (d, J = 257.6 Hz), 159.83, 143.65, 131.03, 129.64, 124.85 (d, J 
= 3.6 Hz), 117.09 (d, J = 21.7 Hz), 112.44 (d, J = 3.9 Hz), 112.26, 79.00 (d, J = 27.8 Hz), 67.59 (d, J = 
96.9 Hz), 28.21, 21.40; 19F NMR (470 MHz, CDCl3) δ -110.55, -110.57; HRMS–ESI (m/z): calcd for 
C12H14FNO (M+H): 207.1059, found 
 
 
2–fluro–benzoic acid 
Yellow solid g, 22mg, 77% yield; 1H NMR (500 MHz, CDCl3) δ 8.10 – 7.99 (m, 1H), 7.59 (tdd, J = 8.4, 
6.6, 1.6 Hz, 1H), 7.28 – 7.15 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 170.11, 170.08, 163.84, 161.75, 
135.80, 135.73, 132.90, 124.26, 124.22, 117.75, 117.67, 117.40, 117.22; 19F NMR (470 MHz, CDCl3) δ -
108.09, -108.10, -108.10, -108.11, -108.13, -108.14. 
4.7 Characterization of Oxazoline Derivatives 
 
4,4–Dimethyl–2–(o–tolyl)–4,5–dihydrooxazole (5a) 
Yellow oil, 1.280 g, 68% yield; Flash chromatography solvent system EtOAc/Hex (1:2) Rf = 0.47; 1H 
NMR (500 MHz, CDCl3) δ 7.75 (d, J = 7.7 Hz, 1H), 7.32 (t, J = 7.4 Hz, 1H), 7.24 – 7.17 (m, 2H), 4.07 (s, 
2H), 2.56 (s, 3H), 1.39 (s, 7H); 13C NMR (126 MHz, CDCl3) δ 162.41, 138.20, 132.14, 132.11, 128.94, 
128.33, 127.93, 125.40, 79.22, 79.19, 67.59, 28.56, 28.53, 21.35. 
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2–(2–Methoxyphenyl)–4,4–dimethyl–4,5–dihydrooxazole (5c) 
Yellow solid, 0.861 g, 42% yield; Melting point 73–75 oC; Flash chromatography solvent system 
EtOAc/Hex/MeOH (4:6:1) Rf = 0.39; 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 7.7 Hz, 1H), 7.41 (t, J = 
7.8 Hz, 1H), 6.96 (d, J = 9.3 Hz, 2H), 4.11 (s, 2H), 3.90 (s, 3H), 1.41 (s, 6H); 13C NMR (126 MHz, 
CDCl3) δ 161.68, 158.61, 132.55, 131.53, 120.41, 111.90, 79.22, 67.43, 56.28, 28.43. 
 
 
 
2–(2–Chlorophenyl)–4,4–dimethyl–4,5–dihydrooxazole (5d) 
Yellow oil 1.422 g, 68% yield; Flash chromatography solvent system EtOAc/Hex (1:2) Rf = 0.42;  1H 
NMR (500 MHz, CDCl3) δ 7.75 (d, J = 7.4 Hz, 1H), 7.43 (d, J = 7.6 Hz, 1H), 7.37 (t, J = 7.6 Hz, 1H), 
7.29 (t, J = 7.6 Hz, 1H), 4.16 (s, 2H), 1.43 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 133.59, 131.61, 131.55, 
130.70, 130.67, 126.72, 126.69, 79.68, 67.86, 28.35, 28.32;  
 
 
4,4–Dimethyl–2–(2–nitrophenyl)–4,5–dihydrooxazole (5x) 
Yellow solid, 1.153 g, 61% yield; Flash chromatography solvent system EtOAc/Hex (1:1) Rf = 0.48; 1H 
NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 6.1 Hz, 1H), 7.66 – 7.53 (m, 2H), 4.10 
(s, 2H), 1.38 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 160.02, 149.10, 132.71, 131.44, 131.21, 124.10, 
80.32, 68.35, 28.04. 
 
 
2–(2–bromophenyl)–4,4–dimethyl–4,5–dihydrooxazole 
Yellow solid, 1.442 g, 57% yield; Melting point 36–38 oC; Flash chromatography solvent system 
EtOAc/Hex (1:1) Rf = 0.65. 1H NMR (500 MHz, CDCl3) δ 7.59 – 7.49 (m, 3H), 7.27 – 7.15 (m, 4H), 4.06 
(s, 2H), 1.33 (s, 5H).13C NMR (126 MHz, CDCl3) δ 161.45, 133.38, 131.33, 131.03, 130.17, 126.87, 
121.62, 79.16, 67.90, 28.10.  
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4,4–Dimethyl–2–(m–tolyl)–4,5–dihydrooxazole (5x) 
Yellow oil 1.247 g, 66% yield; Flash chromatography solvent system EtOAc/Hex (1:1) Rf = 0.42;  1H 
NMR (500 MHz, CDCl3) δ 7.78 (s, 1H), 7.70 (d, J = 6.4 Hz, 1H), 7.32 – 7.21 (m, 2H), 4.08 (s, 2H), 2.36 
(s, 3H), 1.36 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 162.41, 138.20, 132.14, 132.11, 128.94, 128.91, 
128.33, 128.30, 127.93, 125.40, 125.36, 79.22, 67.59, 28.56, 28.53, 21.35;  
 
 
2–(4–Methoxyphenyl)–4,4–dimethyl–4,5–dihydrooxazole (5x) 
Yellow oil 0.841 g, 41% yield; Flash chromatography solvent system EtOAc/Hex/MeOH (4:6:1) Rf = 
0.32. 1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 8.9 Hz, 2H), 6.89 (d, J = 9.0 Hz, 2H), 4.07 (s, 2H), 3.83 
(s, 3H), 1.36 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 162.10, 130.07, 130.06, 120.67, 113.75, 67.53, 
55.48, 28.59.  
 
 
4,4–dimethyl–2–(p–tolyl)–4,5–dihydrooxazole 
Clear oil 1.191 g 63%, yield; Flash chromatography solvent system EtOAc/Hex (1:1) Rf = 0.48; 1H NMR 
(500 MHz, CDCl3) δ 7.79 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 7.9 Hz, 2H), 4.03 (s, 2H), 2.32 (s, 3H), 1.33 (s, 
6H); 13C NMR (126 MHz, CDCl3) δ 162.11, 141.43, 128.93, 128.16, 125.20, 78.97, 67.38, 28.39, 21.48;  
 
 
2–(4–chlorophenyl)–4,4–dimethyl–4,5–dihyrooxazole 
Yellow oil 1.087 g, 52% yield; Melting point 31–33 oC; Flash chromatography solvent system 
EtOAc/Hex (1:2) Rf = 0.44; 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.8 Hz, 1H), 7.34 (d, J = 7.0 Hz, 
1H), 4.08 (s, 1H), 1.35 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 161.31, 137.43, 129.67, 128.63, 126.59, 
79.35, 28.45;  
 
 
4,4–dimethyl–2–(4–nitrophenyl)–4,5–dihyrooxazole 
Yellow oil 1.298 g, 59% yield; Melting point 96–97 oC;  Flash chromatography solvent system 
EtOAc/Hex (1:2) Rf = 0.42. 1H NMR (500 MHz, CDCl3) δ 8.25, 8.24, 8.11, 8.10, 4.16, 1.40. 13C NMR 
(126 MHz, CDCl3) δ 160.48, 149.46, 133.62, 129.32, 123.46, 79.67, 68.09, 28.26. 
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4,4–dimethyl–2–(naphthalene–1–yl)–4,5–dihydrooxazole 
Yellow oil 1.531 g, 68% yield; Melting point 46–47 oC;  Flash chromatography solvent system 
EtOAc/Hex (1:2) Rf = 0.52; 1H NMR (500 MHz, CDCl3) δ 9.07 (d, J = 8.7 Hz, 1H), 8.07 (d, J = 7.1 Hz, 
1H), 7.95 (d, J = 8.2 Hz, 1H), 7.87 (d, J = 8.1 Hz, 1H), 7.61 (t, J = 7.6 Hz, 1H), 7.55 – 7.45 (m, 2H), 4.16 
(s, 2H), 1.49 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 162.09, 133.79, 131.79, 131.26, 128.92, 128.47, 
127.35, 126.43, 126.13, 125.02, 124.73, 78.47, 68.42, 28.66. 
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4.8 1H and 13C NMR copy of Oxazoline Substrates  
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4.9 1H, 13C and 19F NMR copy of fluorinated compounds. 
 
 
	84 
 
 
 
 
 
	85 
 
 
 
	86 
 
 
 
 
 
	87 
 
 
 
 
 
	88 
 
 
 
 
	89 
 
 
 
 
	90 
 
 
	91 
 
 
 
 
	92 
 
 
 
	93 
 
 
 
	94 
 
 
 
	95 
 
 
 
 
 
	96 
 
 
 
 
	97 
 
 
 
 
	98 
 
 
 
	99 
 
 
 
 
	100 
 
 
	101 
 
 
 
 
